🇰🇷 Rytelo in South Korea

Rytelo (IMETELSTAT) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Marketing authorisation holder: GERON
  • Status: likely_approved

Rytelo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is Rytelo approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Rytelo in South Korea?

GERON holds the South Korean marketing authorisation.